The six-gate roadmap, Strategy Lock through Phase 2 Enablement, shows that the sequencing discipline built for one IND is what determines whether a company’s development engine can repeat for a second and third program.
White Paper
From IND to Phase 2: The 24 Months That Determine Whether Your Development Platform Scales
Related Resources
All Resources
case-study
From CDMO to In-House cGMP Manufacturing: Scaling Success in Cell Therapy Technology Transfer
Read More
post
NextGen Lab Moves: Strategies to Maximize Your Laboratory Relocation Plan
Read More
post
The U.S.-China Trade War and Its Impacts on Investigational Drug Supply Chains
Read More
poster
International Technology Transfers: A Playbook for Success
Read More
Let's move from science to success.
Let’s Talk